{{Rsnum
|rsid=2157249
|Gene=APOL2
|Chromosome=22
|position=36234993
|Orientation=plus
|GMAF=0.1924
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene_s=APOL2
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 15.0 | 38.9 | 46.0
| HCB | 0.0 | 0.0 | 100.0
| JPT | 0.0 | 0.0 | 100.0
| YRI | 2.7 | 24.0 | 73.3
| ASW | 3.5 | 35.1 | 61.4
| CHB | 0.0 | 0.0 | 100.0
| CHD | 0.0 | 0.0 | 0.0
| GIH | 2.0 | 35.6 | 62.4
| LWK | 1.8 | 24.5 | 73.6
| MEX | 3.4 | 32.8 | 63.8
| MKK | 7.7 | 44.2 | 48.1
| TSI | 8.8 | 49.0 | 42.2
| HapMapRevision=28
}}{{PMID|18632255|OA=1
}} [[rs9610449]] schizophrenia (377 families, 1161 genotyped members and 647 genotyped affected in total) [[rs9610449]] and [[rs6000200]] associated with risk for schizophrenia in African-Americans. In the combined (AA and EA) sample, two SNPs, [[rs2003813]] and [[rs2157249]]

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}